Topical treatment with eberconazole of the experimental guinea pig cutaneous candidosis;Tratamiento topico de la candidosis cutanea experimental del cobayo con eberconazol

Revista Iberoamericana de Micologia

Volumn 16, Issue 1, 1999, Pages 43-45

  Torres Rodríguez, Josep M ^a,b   Madrenys Brunet, Neus ^a   Montsant, Lourdes ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

Clotrimazole; Cutaneous candidosis; Eberconazole; Experimental model

Indexed keywords

ANTIFUNGAL AGENT; CLOTRIMAZOLE; EBERCONAZOLE; EXCIPIENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; EXPERIMENTAL INFECTION; GUINEA PIG; NONHUMAN; TOPICAL DRUG ADMINISTRATION;

EID: 0032895004     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Torres-Rodríguez JM, Carrillo A, Gallach C, Madrenys N, Julve J. In vitro activity of WAS 2160 and WAS 2163, two new antifungal agents compared with clotrimazole for yeasts and dermatophytes Rev Iber Micol 1988, 5 (Supl 1):84
2. Petranyi G, Ryder NS, Stüta A. Allylamine derivatives:new class of synthetic antifungal agents, inhibiting fungal squalaene epoxidase. Science 1984,224:1239-41.
3. Torres-Rodríguez JM, Madrenys N, Nicolás MC Treatment of guinea pig dermatophytosis with flutrimazole and clotrimazole. Rev Iberoam Micol 1992; 9:91-93
4. Font E, Freixes J, Llauradó X, Julve J. Andreoli R. Actividades complementarias del nuevo antifúngico tópico eberconazol. Rev Farmacol Clin Exp 1993, (Supl. 1): 161 (Abstract 26A).
5. Font E, Freixes J, Juive J. Perfil del nuevo antimicótico tópico eberconazol. Rev Iberoam Micol 1995, 12:16-17.